160EGP
- Active ingredient
- eptifibatide
- Strength
- 2mg/ml
- Form
- vial
- Manufacturer
- patheon italia-spa > merck sharp & dohme scientific office
- Route
- injection
Uses
Acute coronary syndrome and patients undergoing percutaneous coronary intervention.
Do not use if
Active bleeding, severe uncontrolled hypertension, bleeding disorders.
Side effects
Bleeding, hypotension, thrombocytopenia.
Warnings
May cause serious bleeding; monitor closely during treatment.
How it works
Reversible GP IIb/IIIa inhibitor that prevents platelet aggregation.
Storage
Store according to labeled conditions and protect from freezing.